Developing biomarkers for methamphetamine addiction

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 100-103

  Mendelson, John ^a   Baggott, Matthew J ^a   Flower, Keith ^a   Galloway, Gantt ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Addiction; Biomarker; Methamphetamine

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; DEUTERIUM; METHAMPHETAMINE;

ARTICLE; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EXPOSURE; GENE CONTROL; HUMAN; METHAMPHETAMINE ADDICTION; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; RELAPSE; URINALYSIS;

EID: 79953048264     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017128     Document Type: Article

References (29)

1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 2001, 69(3), 89-95.
2. Dufka, F., Galloway, G., Baggott, M., Mendelson, J. The Effects of Inhaled l-Methamphetamine on Athletic performance while riding a stationary bike: a randomized placebo controlled trial. Br. J. Sports Med., 2008, 43(11), 832-835.
3. Mendelson, J., Uemura, N., Harris, D., Nath, R.P., Fernandez, E., Jacob, P., 3rd, Everhart, E.T., Jones, R.T. Human pharmacology of the methamphetamine stereoisomers. Clin. Pharmacol. Ther., 2006, 80(4), 403-420.
4. Mendelson, J.E., McGlothlin, D., Harris, D.S., Foster, E., Everhart, T., Jacob, P., 3rd, Jones, R.T. The clinical pharmacology of intranasal l-methamphetamine. BMC Clin. Pharmacol., 2008, 8, 4.
5. Harris, D.S., Reus, V.I., Wolkowitz, O.M., Mendelson, J.E., Jones, R.T. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology, 2003, 28, 1677-1684.
6. Barbacid, M. Neurotrophic factors and their receptors. Curr. Opin. Cell Biol., 1995, 7(2), 148-155.
7. Banasr, M., Duman, R.S. Keeping 'trk' of antidepressant actions. Neuron, 2008, 59(3), 349-351.
8. Auclair, A., Drouin, C., Cotecchia, S., Glowinski, J., Tassin, J.P. 5- HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur. J. Neurosci., 2004, 20(11), 3073-3084.
9. Piccinni, A., Marazziti, D., Catena, M., Domenici, L., Del Debbio, A., Bianchi, C., Mannari, C., Martini, C., Da Pozzo, E., Schiavi, E., Mariotti, A., Roncaglia, I., Palla, A., Consoli, G., Giovannini, L., Massimetti, G., Dell'Osso, L. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disord., 2008, 105(1-3), 279-283.
10. Mitoma, M., Yoshimura, R., Sugita, A., Umene, W., Hori, H., Nakano, H., Ueda, N., Nakamura, J. Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3- methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress? Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(3), 679-685.
11. Kim, B., Kim, C.Y., Hong, J.P., Kim, S.Y., Lee, C., Joo, Y.H. Brain-derived neurotrophic factor Val/Met polymorphism and bi polar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology, 2008, 58(2), 97-103.
12. Okamoto, T., Yoshimura, R., Ikenouchi-Sugita, A., Hori, H., Umene-Nakano, W., Inoue, Y., Ueda, N., Nakamura, J. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(5), 1185-1190.
13. Grassi-Oliveira, R., Stein, L.M., Lopes, R.P., Teixeira, A.L., Bauer, M.E. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report. Biol. Psychiatry, 2008, 64(4), 281-285.
14. Komulainen, P., Pedersen, M., Hanninen, T., Bruunsgaard, H., Lakka, T.A., Kivipelto, M., Hassinen, M., Rauramaa, T.H., Pedersen, B.K., Rauramaa, R. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol. Learn Mem., 2008, 90(4), 596-603.
15. Gunstad, J., Benitez, A., Smith, J., Glickman, E., Spitznagel, M.B., Alexander, T., Juvancic-Heltzel, J., Murray, L. Serum brainderived neurotrophic factor is associated with cognitive function in healthy older adults. J. Geriatr. Psychiatry Neurol., 2008, 21(3), 166-170.
16. Kim, T.S., Kim, D.J., Lee, H., Kim, Y.K. Increased plasma brainderived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci.Lett., 2007, 423(1), 53-57.
17. D'Souza, D.C., Pittman, B., Perry, E., Simen, A. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology, 2009, 202(4), 569-578.
18. Angelucci, F., Ricci, V., Pomponi, M., Conte, G., Mathe, A.A., Attilio, T.P, et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J. Psychopharmacol (Oxford, England), 2007, 21(8), 820-825.
19. Angelucci, F., Ricci, V., Spalletta, G., Pomponi, M., Tonioni, F., Caltagirone, C., Bria, P. Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers. Eur. Neuropsychopharmacol., 2008, 18(12), 882-887.
20. Joe, K.H., Kim, Y.K., Kim, T.S., Roh, S.W., Choi, S.W., Kim, Y.B., Lee, H.J., Kim, D.J. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcohol Clin. Exp. Res., 2007, 31(11), 1833-188.
21. Mercader, J.M., Fernandez-Aranda, F., Gratacos, M., Ribases, M., Badia, A., Villarejo, C., Solano, R., González, J.R., Vallejo, J., Estivill, X. Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients. Neuropsychobiology, 2007, 56(4), 185-190.
22. Mercader, J.M., Ribases, M., Gratacos, M., Gonzalez, J.R., Bayes, M., de Cid, R., Badía, A., Fernández-Aranda, F., Estivill, X. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav., 2007, 6(8), 706-716.
23. Kim, D.J., Roh, S., Kim, Y., Yoon, S.J., Lee, H.K., Han, C.S., Kim, Y.K. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci. Lett., 2005, 388(2), 112-115.
24. Le Foll, B., Diaz, J., Sokoloff, P. A single cocaine exposure increases BDNF and D3 receptor expression: implications for drugconditioning. Neuroreport, 2005, 16(2), 175-178.
25. Angelucci, F., Gruber, S.H., El Khoury, A., Tonali, P.A., Mathe, A.A. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain. Eur. Neuropsychopharmacol., 2007, 17(12), 756-762.
26. Grace, C.E., Schaefer, T.L., Herring, N.R., Skelton, M.R., McCrea, A.E., Vorhees, C.V., Williams, M.T. (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. Synapse (New York), 2008, 62(2), 110-121.
27. Skelton, M.R., Williams, M.T., Schaefer, T.L., Vorhees, C.V. Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits. Psychoneuroendocrinology, 2007, 32(6), 734-745.
28. Griesbach, G.S., Hovda, D.A., Gomez-Pinilla, F., Sutton, R.L. Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience, 2008, 154(2), 530-540.
29. Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., Funato, H., Watanab Y. Altered expression of neurotrophic factors in patients with major depression. J. Psychiatric Res., 2008, 42(14), 1145-1153.